These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34114163)

  • 1. Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose.
    Sharifi F; Meqbil YJ; Otte A; Gutridge AM; Blaine AT; van Rijn RM; Park K
    Pharm Res; 2021 Jul; 38(7):1221-1234. PubMed ID: 34114163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
    Intra J; Salem AK
    J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and In Vivo Evaluation of Sustained Release Microparticles Loaded with Levothyroxine for Hypothyroidism Treatment.
    Alhawari HH; Abuhamdan RM; Alrashdan M; Al Thaher Y; Shraideh ZA; Abulateefeh SR
    J Pharm Sci; 2024 Jun; 113(6):1566-1571. PubMed ID: 38232803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porous PLGA microparticles prepared with nanosized/micronized sugar particles as porogens.
    Zhang C; Bodmeier R
    Int J Pharm; 2024 Jul; 660():124329. PubMed ID: 38857662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
    Sharifi F; Otte A; Yoon G; Park K
    J Control Release; 2020 Sep; 325():347-358. PubMed ID: 32645336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications.
    Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M
    Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles produced by the hydrogel template method for sustained drug delivery.
    Lu Y; Sturek M; Park K
    Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
    Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres.
    Qiao Z; Yuan Z; Zhang W; Wei D; Hu N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):790-798. PubMed ID: 30892092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules.
    Abulateefeh SR; Alkawareek MY; Alkilany AM
    Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation.
    Park K; Skidmore S; Hadar J; Garner J; Park H; Otte A; Soh BK; Yoon G; Yu D; Yun Y; Lee BK; Jiang X; Wang Y
    J Control Release; 2019 Jun; 304():125-134. PubMed ID: 31071374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Naloxone Concentration Treats Opioid Overdose.
    Aschenbrenner DS
    Am J Nurs; 2022 Feb; 122(2):25. PubMed ID: 35085146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres.
    Li T; Chandrashekar A; Beig A; Walker J; Hong JKY; Benet A; Kang J; Ackermann R; Wang Y; Qin B; Schwendeman AS; Schwendeman SP
    Eur J Pharm Biopharm; 2021 Jan; 158():401-409. PubMed ID: 33122118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
    Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.
    Kazazi-Hyseni F; Landin M; Lathuile A; Veldhuis GJ; Rahimian S; Hennink WE; Kok RJ; van Nostrum CF
    Pharm Res; 2014 Oct; 31(10):2844-56. PubMed ID: 24825756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
    Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
    AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
    Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release.
    Isely C; Hendley MA; Murphy KP; Kader S; Annamalai P; Jabbari E; Gower RM
    Int J Pharm; 2019 Sep; 568():118469. PubMed ID: 31265884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.